Evidence of low incidence of myelodysplastic syndrome (MDS) in patients exposed to bendamustine treatment for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) Meeting Abstract

  


Authors: Burke, J. M.; Bibeau, K.; Kahl, B.; Carson, K. R.; Zelenetz, A. D.; Brander, D. M.; Maddocks, K. J.; Gerecitano, J. F.; Pathak, A. K.; Cheson, B. D.
Abstract Title: Evidence of low incidence of myelodysplastic syndrome (MDS) in patients exposed to bendamustine treatment for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Meeting Title: 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 15 Suppl.
Meeting Dates: 2017 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-05-20
Language: English
ACCESSION: WOS:000411932200042
DOI: 10.1200/JCO.2017.35.15_suppl.e19008
PROVIDER: wos
Notes: Meeting Abstract: e19008 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. John Frank Gerecitano
    153 Gerecitano
  2. Andrew D Zelenetz
    767 Zelenetz
Related MSK Work